Animas Announces Clearance of Uniquely Integrated Meter/Pump System with
Remote Insulin Delivery Capabilities and Compatible Software
WEST CHESTER, Pa., July 1 /PRNewswire/ -- Animas Corporation announced today the clearance of its OneTouch(R) Ping(TM) Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.
"OneTouch Ping provides patients the advanced insulin pump technology from Animas plus the OneTouch blood glucose technology they trust, put together into a system that offers the discretion, convenience and option of remote insulin dosing," said Juan Frias, M.D., Chief Medical Officer and Vice President of Medical Affairs, Animas Corporation. "People using OneTouch Ping will no longer have to access their pump to deliver a bolus, ultimately making life with diabetes a little easier."
OneTouch Ping also marks the first integrated product from two companies within the diabetes care group of Johnson & Johnson, Animas makers of insulin pumps and LifeScan makers of the OneTouch brand of glucose meters and OneTouch(R) Ultra(R) Test Strips.
OneTouch Ping also offers the following:
-- Lifestyle-focused pump performance - the pump can be clipped to a belt, tucked in a pocket, or secured under clothing, is waterproof up to 12 feet for 24 hours and has a color screen for outstanding pump readability
-- Individualized control - delivers lowest basal increments (0.025 U/hr) and lowest bolus increments (0.05 U) available to more precisely match patient insulin needs
-- Proven blood glucose monitoring technology - the meter-remote
|SOURCE Animas Corporation|
Copyright©2008 PR Newswire.
All rights reserved